Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 7, 2022
Patent Application Number
16312843
Date Filed
June 30, 2017
Patent Citations
Patent Primary Examiner
The present invention relates, in part, to isolated antibodies that specifically interact with and show measurable binding affinity to an epitope of platelet derived growth factor C (PDGF-C). Such antibodies may be used for the modulation of PDGF-C activity in or secreted from a cell to study its effects on cell function and, in certain embodiments, for the treatment and/or prevention of a disease or condition associated with PDGF-C signing pathway.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.